Healthcare Services

Cardiac tissue engineering market developments (2026–2030)

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Cardiac Tissue Engineering Market From 2026 To 2030?

The cardiac tissue engineering market has experienced rapid expansion recently. Projections indicate its size will increase from $0.8 billion in 2025 to $0.96 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.4%. This expansion during the historic period is credited to breakthroughs in stem cell research, a rise in cardiovascular disease prevalence, the broadening of translational cardiac research programs, the accessibility of sophisticated biomaterials, and increased academic-industry partnerships.

The cardiac tissue engineering market is poised for significant expansion in the coming years. It is projected to reach $1.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 19.0%. This anticipated growth is driven by factors such as increased investment in regenerative medicine, a greater need for alternatives to traditional donor tissues, the expansion of customized cardiac therapies, the increasing clinical application of engineered tissues, and innovations in biofabrication techniques. Key trends expected during this period involve the heightened development of tissue-engineered heart valves, a growing utilization of stem cell-derived cardiac treatments, wider acceptance of sophisticated biomaterial scaffolds, the broadening of regenerative strategies for myocardial repair, and a stronger emphasis on achieving functional tissue maturation.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report

Which Factors Are Influencing The Growth Of The Cardiac Tissue Engineering Market?

The growing occurrence of cardiovascular diseases is anticipated to propel the future expansion of the cardiac tissue engineering market. This interdisciplinary field focuses on creating biological or bioartificial constructs to repair, regenerate, or replace damaged heart tissue. The increasing prevalence of cardiovascular conditions is mainly attributed to unhealthy lifestyle choices, including poor diet, physical inactivity, smoking, and rising rates of obesity and diabetes. Cardiac tissue engineering addresses cardiovascular diseases by developing biomaterials, cell-based therapies, and bioengineered tissues to repair or regenerate impaired heart muscle and restore cardiac function. For instance, according to the Centers for Disease Control and Prevention, a US-based governmental organization, in May 2023, the percentage of coronary heart disease in female adults aged 18 and over marginally rose to 3.7% in 2023 from 3.6% in 2022. Thus, the escalating incidence of cardiovascular diseases is a key driver for the growth of the cardiac tissue engineering market.

How Is Segmentation Applied In The Cardiac Tissue Engineering Market Segment Analysis?

The cardiac tissue engineering market covered in this report is segmented –

1) By Product: Heart Valves, Vascular Grafts

2) By Material: Stem Cells, Scaffolds

3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications

4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users

Subsegments:

1) By Heart Valves: Bioprosthetic Heart Valves, Tissue-Engineered Heart Valves

2) By Vascular Grafts: Biologic Vascular Grafts, Tissue-Engineered Vascular Grafts

Who Are The Companies Participating In The Cardiac Tissue Engineering Market Environment?

Major companies operating in the cardiac tissue engineering market are Xeltis AG, Humacyte Inc., Carmat S.A., Artivion Inc., Tissue Regenix Group plc, Cytograft Tissue Engineering Inc., BioCardia Inc., Bioheart Inc., Cardio3 Biosciences, Osiris Therapeutics Inc., StemCells Inc., CorMatrix Cardiovascular Inc., Vascugen Inc., CellProthera S.A., Myocardial Solutions Inc., Vericel Corporation, Lineage Cell Therapeutics Inc., Pluristem Therapeutics Inc., Reva Medical Inc., SynCardia Systems Inc.

Get The Full Cardiac Tissue Engineering Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report

Which Region Leads The Cardiac Tissue Engineering Market In Overall Market Size?

North America was the largest region in the cardiac tissue engineering market in 2025. The regions covered in the cardiac tissue engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Tissue Engineering Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report

Browse Through More Reports Similar to the Global Cardiac Tissue Engineering Market 2026, By The Business Research Company

Cardiac Prosthetic Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report

Cardiovascular Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Medical Engineered Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795